Panel Recording on 4.2: Strategic Implications of COVID-19 on Biopharma Companies & Investors
Thank you to all that joined us on Thursday, April 2nd for our live panel discussion where we took a deep dive into the strategic implications of COVID-19 on biopharma companies and investors. It was a great turnout and thank you for your questions. We weren’t able to get to all of the questions during the panel, but we took the time to answer all your questions post-panel.
Please stay tuned for more live panels and webinars in the near future! We look forward to collaborating and sharing our thoughts on industry and market trends.